Kidney Cancer
Cancer of Unknown Primary Site (CUPS)
Life, Laughter, and Dressing Up for Chemo
How living it up keeps Linda Hart-Garrahan moving forward with lymphoma.
Exploring technological advances in patient treatment
Mays Cancer Center is at the forefront of technology-assisted surgical treatments that are improving patient recovery.
Cancer Treatments
Cancer Treatments
Modulation of Sorafenib induced autophagy using hydroxychloroquine in hepatocellular cancer
The PI is studying if sorafenib/hydroxychloroquine (HCQ) will have improved efficacy when compared to sorafenib alone and in patients progressing of sorafenib the addition of HCQ would lead to disease stability in patients with advanced hepatocellular cancer (HCC).
Phase II Trial of Zanzalintinib (XL-092) in Combination with Durvalumab plus Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)
Phase II trial evaluating the combination of XL-092 with durvalumab and tremelimumab in unresectable HCC. This phase II trial design will be preceded by a safety lead in of 9-12 patients.